News Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2026-02-17 EST			5-day change	1st Jan Change
388.00 ^DKK	-0.54%		-7.44%	-16.81%

02-16	STOXX 600 edges higher on financial gains ahead of key earnings	RE
02-13	Diary - Europe's STOXX 600 Corporate Earnings Week Ahead	RE

All News

02-16	STOXX 600 edges higher on financial gains ahead of key earnings	RE
02-13	Diary - Europe's STOXX 600 Corporate Earnings Week Ahead	RE
02-12	Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results	GL
02-09	DNB Carnegie Lowers Price Target for Zealand Pharma to 595 Danish Kroner (610), Reiterates Buy	FW
02-04	U.S. Futures, European Stocks Rise	DJ
01-30	AstraZeneca Strikes Obesity Multibillion-Dollar Deal With China's CSPC Pharmaceuticals -- Update	DJ
01-27	Roche Obesity Shot Helps Patients Lose Weight in Midstage Trial -- Update	DJ
01-21	Zealand Pharma A/S : J.P. Morgan Healthcare Conference (San Francisco)	PU
01-16	SEB Lists Nordic Favorites for Q1, Highlights a Swedish Quartet of Smaller Companies as Most Interesting	FW
01-14	Zealand Pharma A/S Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 01:30 PM
01-12	Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy	AQ
01-09	Zealand Pharma to Boost Drug Discovery via Denmark Supercomputer	MT
01-09	Zealand Pharma to use Gefion AI to accelerate drug discovery	RE
01-09	Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy	GL
01-05	Zealand Pharma to present at the J.P. Morgan Healthcare Conference	GL
12-31	U.S. Futures Fall, European Stocks Mostly Lower	DJ
12-29	Insight: Pills, TikTok and weight-loss apps: the consumer-driven future of GLP-1s	RE
12-23	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
12-19	Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	GL
12-16	Deutsche Bank raises its target price for Zealand Pharma to DKK 450 (430), reiterates hold	FW
12-15	Zealand Pharma A/S - Analyst/Investor Day
12-12	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
12-11	Zealand Pharma A/S : Capital Markets Day 2025	PU
12-11	Zealand Pharma increases its share capital as a result of the exercise of employee warrants	GL
12-11	Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

News Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

All News

Filters